Novartis, Sarepta tipped to drive genomic therapy sales toward $90B
15th May 2025 Uncategorised 0GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by gene therapies such as Sarepta Therapeutics’ Elevidys and Novartis’ Zolgensma.
More: Novartis, Sarepta tipped to drive genomic therapy sales toward B
Source: fierce